Impact of anticancer chemotherapy on the extension of beta-lactamase spectrum: an example with kpc-type carbapenemase activity towards ceftazidime-avibactam

HIGHLIGHTS

• who: Claire Amaris Hobson and collaborators from the UniversitéF-75019, Paris, France have published the paper: Impact of anticancer chemotherapy on the extension of beta-lactamase spectrum: an example with KPC-type carbapenemase activity towards ceftazidime-avibactam, in the Journal: Scientific Reports Scientific Reports

SUMMARY

The culture of Enterobacter cloacae KPC-3 (RD26) and E. coli KPC-2 (RD29) with ACD modified the frequency of resistant mutants to CZA and rifampicin in a variable manner depending on the isolates and the cytotoxic molecules. Compared to the control culture without ACD, the frequency . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.